BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Astrazeneca Pharma India Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
506820
ISIN Demat
INE203A01020
Book Value (Rs)
319.6
NSE Symbol
ASTRAZEN
Divident Yield %
0.38
Market Cap
(Rs In Cr.)
20,988
P/E (TTM)
90.79
EPS (TTM)
92.47
Face Value
(Rs)
2
Date Heading
05-Jan-26 Volumes jump at Timken India Ltd counter
18-Dec-25 AstraZeneca Pharma gets CDSCO nod for import and sale of Datverzo in I
18-Nov-25 AstraZeneca partners with Sun Pharma for second SZC brand in India
17-Nov-25 Astrazeneca Pharma and Sun Pharma form second brand partnership
10-Nov-25 AstraZeneca Pharma slides after Q2 PAT decline 2% QoQ
08-Nov-25 Astrazeneca Pharma India standalone net profit rises 41.09% in the Sep
27-Oct-25 Astrazeneca Pharma India to discuss results
15-Oct-25 Astrazeneca Pharma India Ltd - Launch Of Sodium Zirconium Cyclosilicat
06-Oct-25 AstraZeneca Pharma gets CDSCO nod for Enhertu
03-Oct-25 Astrazeneca Pharma India Ltd - Intimation Under Regulation 30 Of SEBI
19-Sep-25 AstraZeneca Pharma India announces resignation of Head - Legal
19-Sep-25 AstraZeneca Pharma slides as Head of Legal Pankaj Jain resigns
15-Sep-25 Astrazeneca Pharma India Ltd - AstraZeneca Pharma India Limited - Trad
12-Sep-25 Astrazeneca Pharma India Ltd - Disclosure under Regulation 30A of LODR
12-Sep-25 Astrazeneca Pharma India Ltd - Disclosure Under Regulation 30 Of The S
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)